A Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of a Single Dose of Intravenous TD-8954 Compared With Metoclopramide in Critically Ill Patients With Enteral Feeding Intolerance

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

September 30, 2014

Study Completion Date

October 31, 2014

Conditions

Enteral Feeding Intolerance

Interventions

DRUG

TD-8954

DRUG

Metoclopramide

Trial Locations (1)

Royal Adelaide Hospital, Adelaide